About Nutriband Inc. Common Stock
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Market Cap
$0.07B
Employees
3
Listed Since
June 20, 2017
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Website
www.nutriband.comPhone
407 377-6695
Headquarters
121 S. ORANGE AVE.
ORLANDO, FL 32801
CIK
0001676047